Canada markets close in 2 hours 52 minutes

Calithera Biosciences, Inc. (CALA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 09:52AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 97.45k
Enterprise Value -1.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.07
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.03

Trading Information

Stock Price History

Beta (5Y Monthly) -0.17
52-Week Change 3-20.00%
S&P500 52-Week Change 323.57%
52 Week High 30.4999
52 Week Low 30.0100
50-Day Moving Average 30.0236
200-Day Moving Average 30.0346

Share Statistics

Avg Vol (3 month) 31.13k
Avg Vol (10 day) 3280
Shares Outstanding 54.87M
Implied Shares Outstanding 64.87M
Float 84.78M
% Held by Insiders 11.07%
% Held by Institutions 10.00%
Shares Short (Jan 13, 2023) 4417.28k
Short Ratio (Jan 13, 2023) 40.78
Short % of Float (Jan 13, 2023) 48.92%
Short % of Shares Outstanding (Jan 13, 2023) 48.57%
Shares Short (prior month Dec 15, 2022) 4148.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jun 15, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Dec 31, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-56.29%
Return on Equity (ttm)-114.14%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -41.82M
Net Income Avi to Common (ttm)-21.29M
Diluted EPS (ttm)-7.9400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.45M
Total Cash Per Share (mrq)5.22
Total Debt (mrq)1.67M
Total Debt/Equity (mrq)8.17%
Current Ratio (mrq)3.60
Book Value Per Share (mrq)-0.40

Cash Flow Statement

Operating Cash Flow (ttm)-43.61M
Levered Free Cash Flow (ttm)-28.17M